LeMaitre Vascular Inc.

NASDAQ: LMAT · Real-Time Price · USD
95.64
-0.17 (-0.18%)
At close: Aug 15, 2025, 10:01 AM

LeMaitre Vascular Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
64.23M 59.87M 55.72M 54.82M 55.85M 53.48M 48.88M 47.41M 50.12M 47.08M 40.95M 39.03M 42.11M 39.56M 39.5M 38.37M 40.67M 35.88M
Cost of Revenue
19.26M 18.45M 17.13M 17.64M 17.38M 16.81M 17.11M 16.6M 18.03M 16.19M 14.9M 13.96M 14.3M 13.6M 13.55M 13.5M 13.91M 12.08M
Gross Profit
44.97M 41.42M 38.59M 37.18M 38.47M 36.66M 33.27M 30.82M 32.09M 30.88M 26.05M 25.07M 27.81M 25.96M 25.96M 24.87M 26.76M 23.8M
Operating Income
16.14M 12.63M 12.85M 13.15M 14.38M 11.87M 10.21M 9.18M 9.45M 7.87M 5.51M 4.09M 5.78M 5.66M 8.3M 9.07M 11.11M 7.95M
Interest Income
2.98M 2.9M 1.61M 1.2M 1.14M 1M 992K 835K 682K 568K 447K 264K 167K 108K 141K 54K 1K 1K
Pretax Income
18.07M 14.24M 14.02M 14.55M 15.51M 12.8M 11.31M 9.83M 10.32M 8.02M 7.8M 6.15M 5.55M 8M 7.91M 8.43M 10.46M 7.49M
Net Income
13.78M 11.01M 11.18M 11.14M 11.83M 9.89M 8.46M 7.5M 8.1M 6.04M 5.63M 5.46M 3.52M 6.04M 6.17M 6.5M 8.3M 5.93M
Selling & General & Admin
25.29M 24.7M 22.12M 20.37M 19.8M 20.7M 18.71M 17.41M 17.94M 18.83M 15.53M 15.46M 15.57M 15.1M 14.2M 12.95M 13M 13.01M
Research & Development
3.54M 4.09M 3.62M 3.66M 4.28M 4.09M 4.35M 4.22M 4.52M 3.88M 3.55M 3.46M 3.35M 2.93M 3.46M 2.85M 2.65M 2.84M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a 180K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
28.83M 28.79M 25.74M 24.03M 24.09M 24.79M 21.62M 21.64M 22.63M 22.7M 19.09M 18.92M 18.92M 18.03M 17.66M 15.79M 15.65M 15.85M
Interest Expense
1.3M 1.29M 205K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 526K 621K 495K 577K
Selling & Marketing Expenses
14.89M 14.21M 12.63M 11.44M 10.98M 11.69M 10.27M 9.67M 10.22M 10.9M 8.6M 8.23M 8.24M 7.85M 7.45M 6.94M 6.8M 6.47M
Cost & Expenses
48.09M 47.24M 42.86M 41.67M 41.47M 41.6M 38.68M 38.23M 40.66M 38.9M 33.99M 32.88M 33.22M 31.63M 31.2M 29.3M 29.56M 27.94M
Income Tax Expense
4.29M 3.23M 2.84M 3.41M 3.68M 2.91M 2.85M 2.32M 2.22M 1.98M 2.17M 692K 2.03M 1.96M 1.73M 1.93M 2.16M 1.56M
Shares Outstanding (Basic)
22.61M 22.57M 22.51M 22.48M 22.46M 22.36M 22.28M 22.26M 22.21M 22.11M 22.02M 21.98M 21.96M 21.93M 21.86M 21.59M 20.61M 20.55M
Shares Outstanding (Diluted)
22.89M 22.9M 22.9M 22.84M 22.73M 22.57M 22.46M 22.48M 22.45M 22.27M 22.24M 22.22M 22.13M 22.1M 22.14M 21.93M 20.96M 20.85M
EPS (Basic)
0.61 0.49 0.50 0.50 0.53 0.44 0.38 0.34 0.36 0.27 0.26 0.25 0.16 0.28 0.28 0.30 0.40 0.29
EPS (Diluted)
0.60 0.48 0.49 0.49 0.52 0.44 0.38 0.33 0.36 0.27 0.25 0.25 0.16 0.27 0.28 0.30 0.40 0.28
EBITDA
22.02M 18.08M 16.64M 15.57M 16.76M 14.26M 13.76M 11.57M 11.96M 10.53M 10.09M 8.48M 11.34M 10.3M 11.31M 11.98M 13.82M 10.69M
EBIT
19.37M 15.53M 14.23M 13.15M 14.38M 12.8M 12.48M 9.18M 9.63M 8.18M 7.8M 6.15M 8.89M 7.93M 8.43M 9.05M 10.95M 8.07M
Depreciation & Amortization
2.65M 2.55M 2.42M 2.43M 2.38M 2.38M 2.44M 2.4M 2.33M 2.35M 2.29M 2.33M 2.44M 2.37M 2.88M 2.92M 2.87M 2.62M